“GINA 2015: the latest iteration of a magnificent journey.” Jean Bousquet and Marc Humbert. Eur Respir J 2015; 46: 579–582.


Source: Eur Respir J 2015; 46: 1854
Journal Issue: December
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
“GINA 2015: the latest iteration of a magnificent journey.” Jean Bousquet and Marc Humbert. Eur Respir J 2015; 46: 579–582.. Eur Respir J 2015; 46: 1854

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Towards a total ban on links with the tobacco industry: new rules for the ERS.” Klaus F. Rabe, Christina Gratziou, Brian Ward and Florence Berteletti. Eur Respir J 2012; 40: 809–810.
Source: Eur Respir J 2012; 40: 1307
Year: 2012


“Dead space: the physiology of wasted ventilation.” H. Thomas Robertson. Eur Respir J 2015; 45: 1704–1716.
Source: Eur Respir J 2015; 46: 1226
Year: 2015


“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.
Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019
Year: 2020


“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444.
Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017
Year: 2018


“Asthma inhaler adherence determinants in adults: systematic review of observational data.” Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994–1018.
Source: Eur Respir J 2016; 47:1892
Year: 2016


“Lung cancer survival in Norway, 1997–2011: from nihilism to optimism.” Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjørn Møller. Eur Respir J 2016; 47: 275–287.
Source: Eur Respir J 2016; 47: 1297
Year: 2016


“Exercise pulmonary haemodynamics: a test in search of purpose.” J. Gerry Coghlan and Harm Jan Bogaard. Eur Respir J 2016; 47: 1315–1317.
Source: Eur Respir J 2016; 48: 285
Year: 2016


“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057.
Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018
Year: 2018


“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833.
Source: Eur Respir J 2016; 47: 692
Year: 2016


“Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning?” Francesco Blasi and Brian Ward. Eur Respir J 2014; 44: 585–588.
Source: Eur Respir J 2015; 45: 861
Year: 2015


“Umeclidinium in patients with COPD: a randomised, placebo-controlled study.” Roopa Trivedi, Nathalie Richard, Rashmi Mehta and Alison Church. Eur Respir J 2014; 43: 72–81.
Source: Eur Respir J 2014; 44: 555
Year: 2014


“Number needed to treat: enigmatic results for exacerbations in COPD.” Samy Suissa. Eur Respir J 2015; 45: 875–878.
Source: Eur Respir J, 51 (6) 1452165; 10.1183/13993003.52165-2014
Year: 2018


“Bronchodilator combinations for COPD: real hopes or a new Pandora's box?” Nicolas Roche and Pascal Chanez. Eur Respir J 2013; 42: 1441–1445.
Source: Eur Respir J 2014; 43: 658
Year: 2013


“Alveolar macrophages carbon load: a marker of exposure?” Chinedu Nwokoro, Rossa Brugha and Jonathan Grigg. Eur Respir J 2013; 41: 763.
Source: Eur Respir J 2013; 42: 295
Year: 2013


“Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.” Brigitte Benard, Valérie Bastien, Benjamin Vinet, Roger Yang, Maja Krajinovic and Francine M. Ducharme. Eur Respir J 2017; 50: 1700148.
Source: Eur Respir J, 50 (5) 1750148; 10.1183/13993003.50148-2017
Year: 2017



“Long-term volume-targeted pressure-controlled ventilation: sense or nonsense?” Maria Paola Arellano-Maric, Cesare Gregoretti, Marieke Duiverman and Wolfram Windisch. Eur Respir J 2017; 49: 1602193.
Source: Eur Respir J, 50 (1) 1652193; 10.1183/13993003.52193-2016
Year: 2017


“ERS and tobacco harm reduction.” Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman, Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco Control Committee, on behalf of the ERS. Eur Respir J 2019; 54: 1902009.
Source: Eur Respir J, 55 (1) 1952009; 10.1183/13993003.52009-2019
Year: 2020


“Clean air in Europe: beyond the horizon?” Bert Brunekreef, Nino Künzli, Juha Pekkanen, Isabella Annesi-Maesano, Bertil Forsberg, Torben Sigsgaard, Menno Keuken, Francesco Forastiere, Maeve Barry, Xavier Querol and Roy M. Harrison. Eur Respir J 2015; 45: 7–10.
Source: Eur Respir J 2015; 45: 861
Year: 2015


“Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238.
Source: Eur Respir Rev 2015; 24: 545
Year: 2015


“Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia”. Katherine Floyd, Raymond Hutubessy, Kai Kliiman, Rosella Centis, Nina Khurieva, Wieslaw Jakubowiak, Manfred Danilovits, Genadi Peremitin, Salmaan Keshavjee and Giovanni Battista Migliori. Eur Respir J 2012; 40: 133–142.},
Source: Eur Respir J 2012; 40: 800
Year: 2012